[Cellular proliferation and apoptosis in the development and progression of renal diseases:pharmacological interventions in genetically modified animals].
Terzi
F
F
INSERM U426, Faculté X. Bichat, Université Paris VII, Paris.
Burtin
M
M
Friedlander
G
G
D000818:Animals; D017209:Apoptosis; D002455:Cell Division; D004815:Epidermal Growth Factor / Q000502:physiology; D066246:ErbB Receptors / Q000235:genetics / Q000502:physiology; D007674:Kidney Diseases / Q000188:drug therapy* / Q000473:pathology*; D051379:Mice; D018345:Mice, Knockout; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics / Q000502:physiology; D016755:Proto-Oncogene Proteins c-jun / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D018808:Transcription Factor AP-1 / Q000502:physiology
D019253:Proto-Oncogene Proteins c-bcl-2; D016755:Proto-Oncogene Proteins c-jun; D018808:Transcription Factor AP-1; D004815:Epidermal Growth Factor; D066246:ErbB Receptors